enasidenib 50 MG (as enasidenib mesylate 60 MG) Oral Tablet

RxCUI: 1940374
RxNorm name: enasidenib 50 MG (as enasidenib mesylate 60 MG) Oral Tablet
Display name: enasidenib 50 MG (as enasidenib mesylate 60 MG) Oral Tablet
Full name: enasidenib 50 MG (as enasidenib mesylate 60 MG) Oral Tablet
Term type: SY
Status: DailyMed mapping
Updated: 2026-06-04 23:39:12

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Idhifa	ENASIDENIB MESYLATE	Celgene Corporation	a5b4cdf0-3fa8-4c6c-80f6-8d8a00e3a5b6	2025-01-16	Boxed warning, Warnings, Adverse reactions	Exact identifier rxcui: 1940374

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set ID	RxNorm string	TTY	SPL version	Label	Effective
a5b4cdf0-3fa8-4c6c-80f6-8d8a00e3a5b6	enasidenib 50 MG (as enasidenib mesylate 60 MG) Oral Tablet	SY	12	These highlights do not include all the information needed to use IDHIFA safely and effectively. See full prescribing information for IDHIFA. IDHIFA ® (enasidenib) tablets, for oral use Initial U.S. Approval: 2017	20250116
a5b4cdf0-3fa8-4c6c-80f6-8d8a00e3a5b6	enasidenib 50 MG Oral Tablet	SCD	12	These highlights do not include all the information needed to use IDHIFA safely and effectively. See full prescribing information for IDHIFA. IDHIFA ® (enasidenib) tablets, for oral use Initial U.S. Approval: 2017	20250116
a5b4cdf0-3fa8-4c6c-80f6-8d8a00e3a5b6	enasidenib 50 MG Oral Tablet	PSN	12	These highlights do not include all the information needed to use IDHIFA safely and effectively. See full prescribing information for IDHIFA. IDHIFA ® (enasidenib) tablets, for oral use Initial U.S. Approval: 2017	20250116